Overview


Emmanuelle Trombe represents pharmaceutical, medical device and bio-pharmaceutical companies globally in transactional matters in relation to M&A and divestitures, joint ventures and strategic partnerings, large-scale projects, outsourcing projects, product development, licensing agreements and regulatory matters. She also advises venture capital funds and bio-pharmaceutical companies in connection with a broad range of financing activities.

Show More

Results


  • Represented Innate Pharma on its global co-development and commercialization agreement with AstraZeneca for IPH2201, a novel antibody in Phase II development for the treatment of cancer
  • Represented Servier in connection with its strategic partnership with Intarcia Therapeutics. The transaction is one of the largest biotechnology partnership agreements outside the United States
  • Represented Pierre Fabre on its collaboration and licensing agreement with Array Biopharma for the development and commercialization of two novel oncology products, Binimetinib and Encorafenib

Show More

Recognition


  • Chambers Europe 2014 – 2019, Band 1, Pharma/Life Sciences (France): Emmanuelle is recommended for her expertise in “commercial, corporate and regulatory matters in the industry of healthcare and medical devices.” She was described as: “very knowledgeable in pharma, bio-technology and licensing agreements. She is also very business-oriented.”
  • The Legal 500 EMEA 2019, Healthcare and Life Sciences-France
  • The Best Lawyers in France 2019, Biotechnology and Life Sciences Practice

Community


  • Médecins sans Frontières, regularly provides contractual advice to this international humanitarian medical association

Credentials


Education
École Supérieure de Commerce de Paris (ESCP)
University of Paris II Panthéon-Assas, LLM (Maîtrise), Tax and Commercial Law
Complutense University of Madrid, Master AMSEC

Admissions
Paris

Show More

Emmanuelle Trombe

Insights & Events / Media

Paris, France / Speaking Engagements / May 16, 2019

San Francisco, California / McDermott Event / January 7-9, 2019

Shanghai, China / McDermott Event / December 5, 2018

London, United Kingdom / McDermott Event / October 4, 2018

Paris, France / McDermott Event / September 25, 2018

Cambridge, Massachusetts / McDermott Event / September 12, 2018

Paris, France / McDermott Event / July 10, 2018

Boston, Massachusetts / McDermott Event / June 6, 2018

Boston, Massachusetts / Speaking Engagements / June 3, 2018

Shanghai, China / McDermott Event / November 16, 2017

Paris, France / McDermott Event / May 23, 2017

Tokyo, Japan / McDermott Event / January 25 - 26, 2017

San Francisco, California / McDermott Event / January 10, 2017

Publications / February 23, 2015

A Legal Guide to Investing in France for Foreign Investors

Biotech Finances / February 6, 2015

Open Innovation Pharma: Legal instructions (French version)

1

2

3

4